Overview of Approved Anti-HER2 Targeted Therapies for mCRC

14th International Gastrointestinal Cancers Conference (IGICC2024)

S. Kahraman

Adjuvant Therapy for mCRC After Curative Surgery: Treat or Not Treat

14th International Gastrointestinal Cancers Conference (IGICC2024)

F. Dane

Young Onset Colorectal Cancer: A New Epidemic?

Ibrahim Sahin

ASCO® 2023 Insights: "Baseline Liquid Biopsy Results in Treatment Ef…

ecancer

S. Stintzing

ASCO® 2024 Insights: "Randomized ARC-9 Study to Evaluate Etrumadenan…

2024 ASCO® Annual Meeting Insights Hub

Z. Wainberg

ASCO GI 2023 CTCs as Liquid Biopsies in Patients With mCRC vs. Other…

ASCO GI 2023 Conference Coverage

P. Kasi

RFA for Management of Intraductal Cholangiocarcinoma: What is the La…

UCLA Health

D. Issa

Non-Operative Treatment Strategies for Rectal Cancer

Te Vuong

Ongoing GI Oncology Trials at Yale

Yale Cancer Center

P. Kunz, M. Cecchini, J. Lacy

Advances in Hepatocellular Carcinoma Diagnosis and Treatment

Scripps Health

A. Singal

Management of Hepatocellular Carcinoma

8th Annual Liver Conference

A. Singal

Lecture Summary - ASCO 2022 on the Phase 2/3 Study of an Individuali…

ASCO 2022 Conference Coverage

J. Hecht

Colon Cancer Screening: Updates for 2024

Houston Methodist

N. Mathur

ASCO® GI 2024 Insights: "Bi-Weekly FTD/TPI + Bevacizumab vs. FTD/TPI…

Insights from 2024 ASCO® GI Annual Meeting

H. Satake

Biomarker Testing Prior to Therapy Initiation in mCRC

Mark Lewis

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

Treatment of mCRC After Standard Chemotherapy

UChicago Medicine

A. Shergill

March is Colorectal Cancer Awareness Month

David Lieberman

ESMO 2022 on the Global Phase 3 Multiregional Clinical Trial FRESCO-…

ESMO 2022 Conference Coverage

A. Dasari

Surgical Management of Colorectal Cancer for Gastroenterologists

UCSF School of Medicine

M. Varma